Sage Capital Management’s State Street SPDR Bloomberg Convertible Securities ETF CWB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.42M Buy
50,263
+603
+1% +$62.5K 2.12% 11
2026
Q1
$4.55M Buy
49,660
+235
+0.5% +$21.9K 2.14% 11
2025
Q4
$4.41M Buy
49,425
+154
+0.3% +$14K 2.04% 11
2025
Q3
$4.46M Buy
49,271
+25
+0.1% +$2.15K 2.01% 13
2025
Q2
$4.07M Sell
49,246
-2,350
-5% -$185K 1.96% 14
2025
Q1
$3.95M Buy
51,596
+115
+0.2% +$9.09K 2.15% 13
2024
Q4
$4.01M Sell
51,481
-590
-1% -$46.5K 2.03% 13
2024
Q3
$3.99M Sell
52,071
-1,756
-3% -$129K 1.91% 13
2024
Q2
$3.88M Buy
53,827
+170
+0.3% +$12.2K 2.04% 13
2024
Q1
$3.92M Buy
53,657
+118
+0.2% +$8.45K 2.13% 13
2023
Q4
$3.86M Buy
+53,539
New +$3.64M 2.31% 11

Other funds holding CWB

Sage Capital Management's CWB Position: Q2 2026 in Review

Sage Capital Management increased its State Street SPDR Bloomberg Convertible Securities ETF (CWB) stake by 1.2% in Q2 2026, buying an estimated $62.5K and bringing the position to 50,263 shares worth $5.42M. The position accounts for 2.12% of the portfolio, ranked #11.

Sage Capital Management first reported a position in CWB in Q4 2023 and has held it in 11 quarters since. 184 funds tracked by Wall St. Rank hold CWB as of Q2 2026.

  • Sage Capital Management held 50,263 shares of State Street SPDR Bloomberg Convertible Securities ETF worth $5.42M as of Q2 2026.
  • Sage Capital Management bought 603 State Street SPDR Bloomberg Convertible Securities ETF shares in Q2 2026, an estimated $62.5K.
  • State Street SPDR Bloomberg Convertible Securities ETF made up 2.12% of Sage Capital Management's portfolio in Q2 2026, its #11 holding.
  • Sage Capital Management first reported a position in State Street SPDR Bloomberg Convertible Securities ETF in Q4 2023 and has held it in 11 quarters since.
  • 184 funds tracked by Wall St. Rank held State Street SPDR Bloomberg Convertible Securities ETF as of Q2 2026.

Based on Sage Capital Management's 13F filing for Q2 2026, filed 20 Jul 2026.